Table 3 Demographics distribution for DMBT1 expression study (Fig. 6)
From: Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer
Variable | Â | DMBT1 expression cohort |
|---|---|---|
n = 48 | ||
Age | Years | 57.0 (9.4) |
Gender | Male | 40 (83%) |
Female | 8 | |
Clinical stage | 0/1 | 1 |
2 | 3 | |
3 | 5 | |
4 | 36 (75%) | |
Unknown | 3 | |
T stage | T1 | 7 |
T2 | 20 (41%) | |
T3 | 5 | |
T4 | 13 | |
Unknown | 3 | |
N stage | N0 | 8 |
N1 | 5 | |
N2 | 30 (62%) | |
N3 | 5 | |
Disease site | Larynx | 6 |
Oral cavity | 8 | |
Oropharynx | 29 (60%) | |
Nasopharynx | 1 | |
Hypopharynx | 1 | |
Unknown primary | 3 | |
Initial treatment | Chemoradiation | 31 (64%) |
Chemo alone | 1 | |
Radiation alone | 1 | |
Surgery | 12 | |
unknown | 3 | |
ACE comorbidities score | None | 14 |
Mild | 24 (50%) | |
Moderate | 5 | |
Severe | 2 | |
Unknown | 3 | |
BMI | Underweight (< 18.5) | 1 |
Normal (15.5–24.9) | 9 | |
Overweight (25–29.9) | 21 (44%) | |
Obese (30 +) | 14 | |
Unknown | 3 | |
HPV status | Positive | 28 (58%) |
Negative | 17 | |
Unknown | 3 | |
Drinker | Never | 1 |
Current | 37 | |
Former (quit > 12 months) | 7 | |
Unknown | 3 | |
Smoker (cigarettes) | Never | 13 |
Current | 17 | |
Former (quit > 12 months) | 15 | |
Unknown | 3 |